Ebola Vaccine Trials Could Start This Year

🇺🇸 Bloomberg (US) —

AI Summary

Vaccine developers plan to start trials of a new Ebola vaccine targeting the Bundibugyo strain by the end of the year. This acceleration comes amid rising Ebola cases in Congo and Uganda, with CEO Mark Feinberg of IAVI leading the push for human trials.

As Ebola cases rise in Congo and Uganda, vaccine developers are accelerating efforts to combat the rare Bundibugyo strain. IAVI CEO Mark Feinberg says a candidate vaccine could enter human trials by year-end. (Source: Bloomberg)

World Health Ebola vaccine development Bundibugyo strain Congo Uganda IAVI Mark Feinberg public health

Read original source →